Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 

  FDsys > More Information
(Search string is required)
 

15-5982 - BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al


Download Files

Metadata

Document in Context
15-5982 - BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al
December 8, 2016
PDF | More
OPINION. Signed by Judge Peter G. Sheridan on 12/7/2016. (km)
January 5, 2017
PDF | More
MEMORANDUM and ORDER that "A method of treating type 2 diabetes" and related terms, as recited in the '927, '859 and '695 patents, do not require claim construction and should be given its plain and ordinary meaning; "optionally in combination with metformin," as recited in claim 14 of the '859 patent to mean "may be combined with metformin". Signed by Judge Peter G. Sheridan on 1/4/2017. (km)